Invention Grant
- Patent Title: Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer
-
Application No.: US16754285Application Date: 2018-10-15
-
Publication No.: US11713356B2Publication Date: 2023-08-01
- Inventor: Nicolas Poirier , Caroline Mary , Bernard Vanhove
- Applicant: OSE IMMUNOTHERAPEUTICS
- Applicant Address: FR Nantes
- Assignee: OSE IMMUNOTHERAPEUTICS
- Current Assignee: OSE IMMUNOTHERAPEUTICS
- Current Assignee Address: FR Nantes
- Agency: Thompson Coburn LLP
- Agent William A. Holtz
- Priority: EP 306396 2017.10.13
- International Application: PCT/EP2018/078082 2018.10.15
- International Announcement: WO2019/073080A 2019.04.18
- Date entered country: 2020-04-07
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K39/395 ; A61K39/00 ; C07K16/28 ; A61K35/17 ; A61K45/06
Abstract:
The present invention provides new modified anti-SIRPa antibodies linked to an immunotherapeutic agent which are bifunctional and able to specifically enhance the immune response and uses thereof.
Public/Granted literature
- US20210179728A1 MODIFIED ANTI-SIRPA ANTIBODIES AND USES THEREOF Public/Granted day:2021-06-17
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
